Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001385077 | SCV001584788 | pathogenic | Qualitative or quantitative defects of dysferlin | 2024-02-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser1613Valfs*21) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This variant is present in population databases (rs772270346, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. ClinVar contains an entry for this variant (Variation ID: 1072386). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003463002 | SCV004196528 | likely pathogenic | Miyoshi muscular dystrophy 1 | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005023145 | SCV005659326 | likely pathogenic | Miyoshi muscular dystrophy 1; Autosomal recessive limb-girdle muscular dystrophy type 2B; Distal myopathy with anterior tibial onset | 2024-06-24 | criteria provided, single submitter | clinical testing |